MSM: Resurgent epidemics

Current Opinion in HIV and AIDS

Volumn 6, Issue 4, 2011, Pages 326-332

  Morris, Sheldon R ^a   Little, Susan J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

behavior; epidemiology; HIV; MSM; prevention

Indexed keywords

METHAMPHETAMINE;

ADAPTATION; CHLAMYDIA; CRIMINAL BEHAVIOR; DRUG USE; GONORRHEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MALE HOMOSEXUAL; MORBIDITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SOCIAL STIGMA; SYPHILIS; UNSAFE SEX; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; COHORT STUDIES; DISEASE TRANSMISSION, INFECTIOUS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MEDICATION ADHERENCE; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 79959352235     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283476c29     Document Type: Review

References (95)

1. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a newacquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425-1431. (Pubitemid 12240076)
2. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007; 36:294-301. (Pubitemid 47064328)
3. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409. (Pubitemid 40563350)
4. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
5. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170. (Pubitemid 26001148)
6. UNAIDS Report on the Global AIDS Epidemic, 2010; Joint United Nations Programme on HIV/AIDS 2010. This paper gives an excellent global view of HIV.
7. Semaille C, Cazein F, Lot F, et al. Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008. Euro Surveill 2009; 14:14.
8. Le Vu S, Le Strat Y, Barin F, et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis 2010; 10:682-687. The most recent paper with incidence estimates in a resource-rich country.
9. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529.
10. Stall R, Duran L, Wisniewski SR, et al. Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav 2009; 13:615-629.
11. Jansen IA, Geskus RB, Davidovich U, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011; 25:493-501. A long-term cohort study with detailed analysis of HIV transmission among MSM.
12. van Griensven F, Varangrat A, Wimonsate W, et al. Trends in HIV prevalence, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003-2007. J Acquir Immune Defic Syndr 2009; 53:234-239.
13. Ruan Y, Jia Y, Zhang X, et al. Incidence of HIV-1, syphilis, hepatitis B, and hepatitis C virus infections and predictors associated with retention in a 12- month follow-up study among men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 2009; 52:604-610.
14. Yang H, Hao C, Huan X, et al. HIV incidence and associated factors in a cohort of men who have sex with men in Nanjing, China. Sex Transm Dis 2010; 37:208-213.
15. Xu JJ, Zhang M, Brown K, et al. Syphilis and HIV seroconversion among a 12- month prospective cohort of men who have sex with men in Shenyang, China. Sex Transm Dis 2010; 37:432-439.
16. Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review. PLoS Med 2007; 4:e339.
17. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5:e11068. The paper by Das et al. demonstrated an ecological association of a reduction in total population level viral load with declining numbers of new HIV diagnoses. These data were from San Francisco where the vast majority of HIV cases followed was MSM. These provocative data suggest that expanding HIV treatment will reduce HIV incidence. However, these studies do not count people not in care and the relationship could be confounded by other factors.
18. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376:532-539. Motaner et al. also show an ecological association of population level viral load with declining numbers of new HIV diagnoses. The effect observed was driven primarily by the reduction in HIV incident cases in intravenous drug users.
19. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48-57.
20. A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR Morb Mortal Wkly Rep 1982; 31:305-307.
21. Subpopulation estimates from the HIV incidence surveillance system - United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:985-989.
22. Kingsley LA, Detels R, Kaslow R, et al. Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet 1987; 1:345-349.
23. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8:553-563.
24. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39:1048-1063. This paper is the most complete review of the risk of HIV transmission from anal sex.
25. Jameson DR, Celum CL, Manhart L, et al. The association between lack of circumcision and HIV, HSV-2, and other sexually transmitted infections among men who have sex with men. Sex Transm Dis 2010; 37:147-152.
26. McDaid LM, Weiss HA, Hart GJ. Circumcision among men who have sex with men in Scotland: limited potential for HIV prevention. Sex Transm Infect 2010; 86:404-406.
27. Sanchez J, Sal YRVG, Hughes JP, et al. Male circumcision and risk of HIV acquisition among MSM. AIDS 2010; 25:519-523.
28. Templeton DJ, Millett GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis 2010; 23:45-52.
29. Gust DA, Wiegand RE, Kretsinger K, et al. Circumcision status and HIV infection among MSM: reanalysis of a phase III HIV vaccine clinical trial. AIDS 2010; 24:1135-1143.
30. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005; 2:e298.
31. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
32. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
33. Smith DK, Taylor A, Kilmarx PH, et al. Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep 2010; 125 (Suppl 1):72-82. A report on the status of circumcision for MSM on HIV transmission.
34. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599. The paper by Grant et al. demonstrates that ART is effective in prevention of HIV acquisition but does not begin to answer how this could be implemented or how real world effectiveness will be.
35. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
36. Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis 2011; 52 (Suppl 2):S214-S222.
37. Mehta SA, Silvera R, Bernstein K, et al. Awareness of postexposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect 2011. [Epub ahead of print]
38. Glass TR, Battegay M, Cavassini M, et al. Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2010; 54:197-203. The paper by Glass et al. is important in that it shows the long-term ART adherence reported by a large cohort of HIV-infected individuals and that 100% adherence was not the norm. However, the number of missed doses is not well quantified and, therefore, is uncertain whether there was significant viral breakthrough.
39. Rieder P, Joos B, von Wyl V, et al. HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS 2010; 24:1177-1183. The paper by Rieder et al. shows that transmission of HIV could be traced to individuals who had discontinued ART in the Swiss Cohort after early treatment for primary infection. This suggests that continued use of ART could have prevented these transmissions.
40. Jeffries WL, Zsembik BA, Peek CW, Uphold CR. A longitudinal analysis of sociodemographic and health correlates of sexual health among HIV-infected men in the USA. Sex Health 2009; 6:285-292.
41. Thiede H, Jenkins RA, Carey JW, et al. Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health 2009; 99 (Suppl 1):S157-S164.
42. Hasse B, Ledergerber B, Hirschel B, et al. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-1322. The paper by Hasse et al. reported reasons for condom use among a large cohort of HIV-infected men. In particular, MSM were less likely to use a condom with a seroconcordant partner and if they were on ART. This suggests MSM make decisions on condom use based on a perception of lower transmission risk.
43. Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr 2009; 51:349-355.
44. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
45. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep 2007; 4:165-172.
46. Rudy ET, Shoptaw S, Lazzar M, et al. Methamphetamine use and other club drug use differ in relation to HIV status and risk behavior among gay and bisexual men. Sex Transm Dis 2009; 36:693-695.
47. Carey JW, Mejia R, Bingham T, et al. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behav 2009; 13:1084-1096.
48. Drumright LN, Gorbach PM, Little SJ, Strathdee SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav 2009; 13: 328-336.
49. Gorbach PM, Weiss RE, Jeffries R, et al. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr 2011; 56:176-182.
50. Degenhardt L, Mathers B, Guarinieri M, et al. Meth/amphetamine use and associated HIV: implications for global policy and public health. Int J Drug Policy 2010; 21:347-358.
51. Prestage G, Jin F, Kippax S, et al. Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med 2009; 6:2311-2320.
52. Mansergh G, Koblin BA, McKirnan DJ, et al. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med 2010; 7:e1000329.
53. Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: relationship to sexual risk behaviors. Arch Sex Behav 2009; 40:273-279.
54. Semple SJ, Zians J, Strathdee SA, Patterson TL. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav 2009; 38:583-590.
55. Cook RL, McGinnis KA, Samet JH, et al. Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men. J Gen Intern Med 2010; 25:115-121. This study shows that men receiving prescription of EDDs did not have higher sexual risk behaviors.
56. Trotta MP, Ammassari A, Murri R, et al. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. AIDS Patient Care STDS 2008; 22:291-299. (Pubitemid 351562963)
57. McFarland W, Chen YH, Raymond HF, et al. HIV seroadaptation among individuals, within sexual dyads, and by sexual episodes, men who have sex with men, San Francisco, 2008. AIDS Care 2010; 23:261-268.
58. McConnell JJ, Bragg L, Shiboski S, Grant RM. Sexual seroadaptation: lessons for prevention and sex research from a cohort of HIV-positive men who have sex with men. PLoS One 2010; 5:e8831.
59. Butler DM, Smith DM. Serosorting can potentially increase HIV transmissions. AIDS 2007; 21:1218-1220. (Pubitemid 46763297)
60. Golden MR, Stekler J, Hughes JP, Wood RW. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr 2008; 49:212-218.
61. Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23:243-252.
62. Philip SS, Yu X, Donnell D, et al. Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort. PLoS One 2010; 9:e12662 . In the paper by Philip et al., a well characterized cohort of MSM who were in a behavioral intervention trial and had frequent HIV testing demonstrated a reduction in HIV acquisition risk if they reported serosorting. This suggests that regular HIV testing combined with serosorting could reduce HIV transmission.
63. Smith DM, May SJ, Tweeten S, et al. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 2009; 23:225-232.
64. Fisher M, Pao D, Brown AE, et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010; 24:1739-1747. An excellent analysis of determinants of HVI transmission among MSM.
65. Lee SS, Tam DK, Tan Y, et al. An exploratory study on the social and genotypic clustering of HIV infection in men having sex with men. AIDS 2009; 23:1755-1764.
66. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997; 11:641-648. (Pubitemid 27135886)
67. Beyrer C, Trapence G, Motimedi F, et al. Bisexual concurrency, bisexual partnerships, and HIV among southern African men who have sex with men. Sex Transm Infect 2010; 86:323-327.
68. Ha TH, Liu H, Cai Y, Feng T. Concurrent sexual partnerships among men who have sex with men in Shenzhen, China. Sex Transm Dis 2010; 37:506-511.
69. Eaton LA, Kalichman SC, Cherry C. Sexual partner selection and HIV risk reduction among Black and White men who have sex with men. Am J Public Health 2010; 100:503-509.
70. Cassels S, Pearson CR, Walters K, et al. Sexual partner concurrency and sexual risk among gay, lesbian, bisexual, and transgender American Indian/Alaska natives. Sex Transm Dis 2010; 37:272-278.
71. Bohl DD, Raymond HF, Arnold M, McFarland W. Concurrent sexual partnerships and racial disparities in HIV infection among men who have sex with men. Sex Transm Infect 2009; 85:367-369.
72. Frye V, Koblin B, Chin J, et al. Neighborhood-level correlates of consistent condom use among men who have sex with men: a multilevel analysis. AIDS Behav 2010; 14:974-985.
73. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28:579-597.
74. Templeton DJ, Jin F, Imrie J, et al. Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia. Sex Transm Infect 2008; 84:361-363.
75. Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006; 43:1284-1289. (Pubitemid 44706454)
76. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41:67-74. (Pubitemid 40863746)
77. Dang T, Jaton-Ogay K, Flepp M, et al. High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clin Infect Dis 2009; 49:1532-1535.
78. Truong HM, Kellogg T, Klausner JD, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect 2006; 82:461-466.
79. Spielmann N, Munstermann D, Hagedorn HJ, et al. Time trends of syphilis and HSV-2 co-infection among men who have sex with men in the German HIV-1 seroconverter cohort from1996-2007. Sex Transm Infect 2010; 86:331-336.
80. Baral S, Kizub D, Masenior NF, et al. Male sex workers in Moscow, Russia: a pilot study of demographics, substance use patterns, and prevalence of HIV-1 and sexually transmitted infections. AIDS Care 2010; 22:112-118.
81. Mayer KH, O'Cleirigh C, Skeer M, et al. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from a Boston community health centre. Sex Transm Infect 2010; 86:66-70.
82. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
83. Ayala G, Beck J, Lauer K, et al. Social discrimination against men who have sex with men (MSM): implications for HIV policy and programs. The Global Forum on MSM and HIV 2010 Policy Brief.
84. Beyrer C, Baral SD, Walker D, et al. The expanding epidemics of HIV type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency. Epidemiol Rev 2010; 32:137-151. This paper is the best overall description of the state of HIV in resource-limited countries.
85. Sayles JN, Wong MD, Kinsler JJ, et al. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med 2009; 24:1101-1108.
86. Smith AD, Tapsoba P, Peshu N, et al. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet 2009; 374:416-422.
87. Csete J, Dube S. An inappropriate tool: criminal law and HIV in Asia. AIDS 2010; 24 (Suppl 3):S80-S85.
88. Jurgens R, Cohen J, Cameron E, et al. Ten reasons to oppose the criminalization of HIV exposure or transmission. Reprod Health Matters 2009; 17:163-172.
89. UNAIDS. Criminal Law, Public Health and HIV Transmission: a Policy Options Paper; 2002.
90. International consultation on the criminalization of HIV transmission: 31 October 2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007. Reprod Health Matters 2009; 17:180-186.
91. Lewis F, Hughes GJ, Rambaut A, et al. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 2008; 5:e50.
92. Brenner BG, Roger M, Moisi DD, et al. Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 2008; 22:2509-2515.
93. Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:277-282.
94. Rutherford GW, McFarland W, Spindler H, et al. Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics. BMC Public Health 2010; 10:447.
95. Hall HI, Green TA, Wolitski RJ, et al. Estimated future HIV prevalence, incidence, and potential infections averted in the United States: a multiple scenario analysis. J Acquir Immune Defic Syndr 2010; 55:271-276. Using methods for calculating HIV incidence, this modeling exercise demonstrates that declines of more than 50% will be needed to see leveling of HIV prevalence. This supports the need for an ongoing multilevel HIV control strategy.